[2] Hydroxocobalamin is administered via intramuscular or intravenous injection to treat and prevent vitamin B deficiency, particularly in conditions like pernicious anemia where oral B absorption is impaired
AOD 9604 AOD 9604 Peptide available in a 5 mg vial
This is the broader theme in Metos companion piece: peptides and GLP-1s are not inherently competitors
It is important for patients and practitioners to understand that 'investigational' or 'research' status does not equate to safety, efficacy, or regulatory approval for human use outside of controlled clinical trial settings
Documented side effects are usually mild to moderate: Injection-site pain, redness, or bruising Flushing Increased heart rate Nausea or gastrointestinal upset Headache Urinary changes or a fishy body odor at higher choline doses Because these are compounded products, sterile technique, pharmacy sourcing, and formulation verification matter